Financhill
Back

VYNE Therapeutics Stock Predictions

VYNE Therapeutics Stock Forecast

  • Is VYNE Therapeutics Stock Undervalued?
    The current VYNE Therapeutics [VYNE] share price is $0.95. The Score for VYNE is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • VYNE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will VYNE Therapeutics Stock Go Up Next Year?

Data Unavailable

VYNE Therapeutics Stock Rating

Data Unavailable

VYNE Therapeutics Stock Price History

Is VYNE stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VYNE is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
vynetherapeutics.com

52-Week Data

52-Week High:
4.30
52-Week Low:
0.95

Prediction Charts

Market Cap:
15.8M
Price in USD:
0.95
Volume:
91.9K
Beta:
1.49

Technical Analysis

SMA50:
1.46
SMA100:
2.02
SMA200:
2.18
52-Wk Change:
-62.75%

Stock Predictions

  • Is VYNE Therapeutics stock public?
    Yes, VYNE Therapeutics is a publicly traded company.
  • What is the VYNE Therapeutics stock quote today?
    The VYNE Therapeutics stock price is 0.95 USD today.
  • How to buy VYNE Therapeutics stock online?
    You can buy VYNE Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-12 1.30 1.25 1.30 1.18
May-13 1.25 1.31 1.33 1.22
May-14 1.30 1.26 1.32 1.25
May-15 1.26 1.25 1.32 1.23
May-16 1.26 1.22 1.27 1.21
May-19 1.23 1.22 1.26 1.18
May-20 1.22 1.15 1.25 1.14
May-21 1.15 1.00 1.15 1.00
May-22 1.02 1.00 1.06 0.99
May-23 0.98 1.04 1.08 0.96
May-27 1.08 1.00 1.09 0.99
May-28 1.00 0.98 1.02 0.97
May-29 0.99 0.97 0.99 0.96
May-30 0.96 0.95 0.99 0.95

VYNE Therapeutics Earnings

Data Unavailable

VYNE Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.05 per share, and a decrease next year of $0.00 per share.

* VYNE Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.